KromaTiD receives third patent, expands mutation testing capabilities
FORT COLLINS -- KromaTiD announced it received its third U.S. patent to expand its full genome screening platform to include a new set of unique methods for understanding the structure of novel... Read More
Tuesday September 22, 2015 0 comments
KromaTiD to distribute proprietary products and services in Japan
FORT COLLINS -- KromaTiD , a bioscience company dedicated to creating new products for genetic disease research, mutation detection and chromosome analysis, today announced an agreement with... Read More
Monday May 18, 2015 0 comments
KromaTiD selects tebu-bio to distribute its products throughout Europe
FORT COLLINS - KromaTiD announced it will partner with France-based tebu-bio to distribute its proprietary dGH and Pinpoint FISH products and services throughout Europe. Tebu-bio has... Read More
Tuesday February 10, 2015 0 comments
KromaTiD launches dGH line of discovery and detection tools for disease-causing mutations
FORT COLLINS -- KromaTiD, Inc . has launched its directional Genomic Hybridization (dGH) line of mutation discovery and detection assays. Now available, KromaTiD dGH products provide... Read More
Wednesday December 11, 2013 0 comments
KromaTiD launches new dGH line of genetic mutation discovery tools
FORT COLLINS - KromaTiD Inc . today announced the launch of its directional Genomic Hybridization (dGH) line of mutation discovery and detection assays. The new products provide researchers... Read More
Monday October 21, 2013 0 comments
IN Sponsors
Browse
Entrepreneurial by Nature
